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We describe a homozygous copy-number variant
that disrupts the function of Dock2 in a commercially
available C57BL/6 mouse strain that is widely used
for backcrossing. This Dock2 allele was presumed
to have spontaneously arisen in a colony of Irf5
knockout mice. We discovered that this allele has
actually been inadvertently backcrossed into multi-
ple mutant mouse lines, including two engineered
to be deficient in Siae and Cmah. This particular
commercially obtained subline of C57BL/6 mice
also exhibits several striking immune phenotypes
that have been previously described in the context
of Dock2 deficiency. Inadvertent backcrossing of a
number of gene-targeted mice into this background
has complicated the interpretation of several immu-
nological studies. In light of these findings, published
studies involving immune or hematopoietic pheno-
types in which these C57BL/6 mice have been used
as controls, as experimental animals, or for back-
crossing will need to be reinterpreted.
INTRODUCTION
Over the last three decades, gene targeting has emerged as
a powerful tool for functional analyses of immune genes in vivo.
It has become a common practice to backcross gene-targeted
mice for about ten generations into the C57BL/6 background to
facilitate comparisons among gene-targeted mice, as well as for
adoptive transfer experiments. However, numerous C57BL/6
sublines are in use around the world (Zurita et al., 2011), and the
potential effectof variabilityamong theseC57BL/6sublineson im-
mune phenotypes is often not considered.
We had previously described defects in B cell development in
two engineered mice strains with altered sialic acid physiology
(Cariappa et al., 2009). Mice with a germline loss of either Siae
(sialic acid acetyl esterase) or Cmah (cytidine monophosphate-
N-acetylneuraminic acid hydroxylase) were found to lack mar-
ginal zone (MZ) B cells and exhibited hyperactive B cell receptorCell
This is an open access article under the CC BY-Nsignaling (Cariappa et al., 2009). Given that these mice generate
altered forms of sialic acid that are not recognized by key regu-
latory Siglecs expressed on B cells (such as CD22/Siglec-2 and
Siglec-G), the defects in B cell development observed in these
mice were presumed to arise from perturbations in Siglec func-
tion (Cariappa et al., 2009; Pillai et al., 2009). In addition, the
observed phenotypes were largely compatible with previous
studies of Siglec function (Mahajan and Pillai, 2016; Pillai et al.,
2009). Both SiaeDex2/Dex2 and Cmah knockout mice had been
backcrossed into a specific commercially obtained C57BL/6
background for ten generations (Cariappa et al., 2009; Hedlund
et al., 2007).We found that Siae-deficient mice unexpectedly lost
their aberrant B cell development phenotype upon backcrossing
for 13 additional generations into the C57BL/6J (Jackson Labo-
ratory) background. We created an independent knockout line of
Siae-deficient mice in the C57BL/6N background, and these
mice exhibited no defects in B cell development.
Given these discrepant results, we re-examined the genetic
basis of aberrant B cell development in SiaeDex2/Dex2 mice using
genetic crosses, SNP arrays, and whole-genome sequencing.
These studies revealed that the defects in B cell development
were not linked to Siae, which is present on chromosome 9
(chr9), but instead to a gene encoding a guanine nucleotide
exchange factor, Dock2, on chromosome 11 (chr11).
Whole-genome sequencing revealed a duplication of exons 28
and 29 ofDock2. Surprisingly, an identical mutation inDock2 had
been previously reported in two colonies of Irf5/ mice (Purtha
et al., 2012). Given that the same mutation in Dock2 was identi-
fied in multiple gene-targeted mouse colonies despite different
embryonic stem cell (ESC) lines being used to generate these
mice, it appeared that it was most likely introduced during back-
crossing into the C57BL/6 background. Furthermore, the pres-
ence of C57BL/6N SNPs in close linkage with the duplication
suggests that it arose in a C57BL/6N subline. We were able to
find this Dock2 variant (Dock2Hsd) in the homozygous state in
the colony of C57BL/6NHsd mice maintained at Harlan Sprague
Laboratories (now Envigo Biosciences). We also identified the
Dock2Hsd variant in a colony of Cmah knockout mice that had
been backcrossed into C57BL/6 mice obtained directly from
Harlan. Examination of a range of other commercially available
C57BL/6J and C57BL/6N mice revealed only wild-type Dock2.
It is therefore likely that the Dock2Hsd variant originally aroseReports 15, 1901–1909, May 31, 2016 ª 2016 The Author(s). 1901
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Siae-Deficient Mice Exhibit a Background-Dependent Increase in CD8+ MP Cells and a Loss of MZ B Cells
(A) The proportion of CD8+ MP cells in the spleens of 1- to 3-month-old N10-Siae mice with age-matched C57BL/6J controls.
(B) CD8+ MP and MZ B cells in N10-Siae, N23-Siae, Siaetm1a/tm1a, and C57BL/6J mice. The data shown are representative of five mice.
See also Figure S1.within the C57BL/6NHsd mouse colony at Harlan. This study
raises concerns that many other lines of gene-targeted mice
bearing hematopoietic phenotypes may have been inadvertently
compromised by backcrosses involving the use of C57BL/
6NHsd mice.
RESULTS
The Loss of MZ B Cells and Enhanced CD8+ Memory
T Cell Phenotype Observed in SiaeDex2/Dex2 Mice Is Not
Linked to the Loss of Siae
We previously reported that SiaeDex2/Dex2 mice, which were
backcrossed into the C57BL/6 background for ten generations
(henceforth referred to as N10-Siae mice), show a profound
loss of MZ B cells (Cariappa et al., 2009). In subsequent studies,
we noted that N10-Siae mice also exhibit a marked increase in
CD8+ CD44+ CD122hi memory-phenotype (MP) cells in the blood
and spleen (Figure 1A). Surprisingly, both the defect in MZ B cell
development and the increase in CD8+ MP cells were lost upon
further backcrossing of N10-Siae mice into the C57BL/6J back-
ground for an additional 13 generations (henceforth referred to1902 Cell Reports 15, 1901–1909, May 31, 2016as N23-Siae mice) (Figure 1B). To further determine whether
the loss of Siae per se was responsible for any of the N10 pheno-
types, we generated an independent line of Siae-deficient mice
(Siaetm1a/tm1a) using an ESC clone bearing a gene-targeted allele
of Siae (Siaetm1a(EUCOMM)Wtsi; MGI: 4842607) in the C57BL/6N
background (Figure S1). These mice also exhibited normal
numbers of MZ B cells and no increase in CD8+ MP cells, con-
firming that the loss of Siae per se was not responsible for the
phenotypes previously observed in N10-Siae mice (Figure 1B).
The Phenotypes Observed in N10-Siae Mice Are
Inherited in a Mendelian Fashion and Linked to a Locus
Distinct from Siae
To begin to identify the genetic locus responsible for the anom-
alous phenotypes observed in N10-Siae mice, we did a test
cross to assess the inheritance pattern. N10-Siae 3 C57BL/6J
mice (F1) were generated and backcrossed to N10-Siae mice.
We found that the increase in CD8+ MP cells was a Mendelian
recessive trait that segregated independently of Siae (Figure 2A).
In addition, analysis of these mice showed a 100% linkage
between the loss of MZ B cells and an increase in CD8+ MP
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Figure 2. Hematopoietic Phenotypes Observed in N10-Siae Mice Are Mendelian, Recessive, and Unlinked to Siae
(A) (N10-Siae 3 C57BL/6J) F1 animals have a normal CD8+ MP cell compartment. Upon subsequent backcrossing to the N10-Siae background, Siae does not
segregate with the altered CD8+MP cells (n = 13). An approximately equal number of mice with (n = 79) and without (n = 77) the phenotype (<40% and >40%CD8
MP cells, respectively) are observed.
(B) A strong correlation between loss of MZ B cells and increase in CD8 MP is observed.
(C) About 25% of Siae+/+ (wild-type) mice obtained from an intercross between heterozygous N10-Siae mice exhibit normal CD8+ MP cells.T cells, suggesting that a single genetic locus was likely respon-
sible for both phenotypes (Figure 2B). Because the proportion of
CD8+ MP cells in blood could be easily measured, we used this
trait for mapping the pathogenic locus. We also found that 4 of
18 mice that lacked both copies of the SiaeDex2 allele had an
abnormal CD8+ MP population, suggesting that Siae had no
contribution to these observed phenotypes (Figure 2C).
A Genetic Marker on Chr11 Segregates with the N10-
Siae Phenotype
In parallel, we performed a whole-genome SNP array (Affymetrix
Mouse Diversity array) on two homozygous N10-Siae mice that
exhibited a loss of MZ B cells and an increased proportion of
CD8+MP cells. The N10-Siaewhole-genome SNP arrays yielded
an average call rate of 99%, with 98.7% homozygosity. Publicly
available SNP array data from various 129 substrains and
C57BL/6 sublines were used for comparison (Didion et al.,
2012). The 538,667 SNPs showed a 100% call rate across all ar-
rays. Given that the SiaeDex2 allele was generated in an R1 ESC
that is derived from the (129X1/SvJ 3 129S1/Sv)F1-Kitl+ back-
ground (Nagy et al., 1993), it was not surprising that all SNPs
(276 of 276) in a 6 Mbp region surrounding the Siae locus
(chr9:35022155–41040054) that differed from the C57BL/6 refer-
ence genome were of 129 origin (Figure 3A) (Table S1). Surpris-ingly, all 129 origin SNPs were retained in the N23-Siae mice,
suggesting that 13 additional generations of backcrossing into
C57BL/6J mice had had no further effect on reducing the 129
contribution on chr9 (Figure S3). Considering that 17.4% of
the 538,667 SNPs calls analyzed in thewhole-genomeSNP array
were different between the 129 and the C57BL/6 backgrounds
and that we did not find any genomic region containing two or
more contiguous SNPs of 129 origin outside of the chr9 locus
containing Siae, we recognized that it was extremely unlikely
that a mutation in the gene-targeted ESC clone of 129 origin
had been retained in the N10-Siae mice.
All (123 of 123) SNPson the remainingN10-Siae chromosomes
that differed from the C57BL/6J allele matched the C57BL/6N
consensus allele (shared between C57BL/6NTac, C57BL/6Nci,
and C57BL/6NCrl), suggesting that the pathogenic locus could
have arisen from a C57BL/6N strain used previously for back-
crossing. We next tested the genetic linkage to a few randomly
chosen candidate C57BL/6N SNPs in the (C57BL/6N 3
C57BL/6J) test crosses (Figures 2A and 2B). Fortuitously, a
SNP of C57BL/6N origin, rs29391827, on chr11 (50962622) was
linked to the increase in CD8+ MP cells in the blood of 18 mice
(Figure 3B). The linkage to rs29391827 was validated in a larger
cohort of 156 mice and estimated to be at a distance of about
8.3 cM (Figure 3C).Cell Reports 15, 1901–1909, May 31, 2016 1903
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Figure 3. A SNP on Chr11 Segregates with
Increase in CD8 MP T Cells
(A) Whole-genome SNP array revealed 399 SNPs
that differ between N10-Siae and C57BL/6J. On
chr9, 276 SNPs (blue triangles) in the Siae locus
are shared by 129 strains; 123 SNPs (red triangles)
appear to be of C57BL/6N origin.
(B) Linkage between candidate SNPs and CD8+
MP expansion in the progeny of test crosses
(n = 18) described in Figure 2A. A SNP on chr11
(rs29391827) was found to segregate with the
CD8 MP (n = 18).
(C) The observation in (B) was validated in a larger
cohort (n = 156).
See also Figure S2 and Table S1.A Region on chr11:30552213–35421130 Is Tightly
Associated with the N10-Siae Phenotype
We next performed whole-genome sequencing of an N10-Siae
mouse that exhibited the phenotypic changes described. Sin-
gle-end sequencing was performed for 85 cycles on a NextSeq
500 instrument, yielding a total of 40 Gbp of sequence data.
Of the reads, 93.9% mapped to the reference mouse genome
(65.42% of the reads mapped to unique sites on the genome).
Ameancoveragedepth of 15.33-foldwasobtained. TheGenome
Analysis Toolkit (GATK) variant calling pipeline was used to iden-
tify positions on chr11 that differed from the reference genome
(Figure S3) (McKenna et al., 2010). This analysis confirmed the re-
sults of the whole-genome SNP array (for SNPs with adequate
sequencing coverage) and revealed a few additional SNPs that
were not covered by the SNP array that differed between N10-
Siae and C57BL/6J. All protein coding variants (3 of 3) that we
observed within 25Mbp of rs29391827 on chr11 were previously
reported SNPs present in one or more inbred mouse strains
(rs240617401, rs8261521, and rs6268547). Because structural
variants could not be ruled out on the basis of this analysis,
we used a panel of SNPs that differed between N10-Siae and
C57BL/6J to analyze mice (Figure 3) that showed discrepant
phenotypes with respect to rs29391827. This allowed us to
progressively narrow the pathogenic genetic locus to a 5 Mbp
region on chr11 (30552213–35421130) (Figure S4).1904 Cell Reports 15, 1901–1909, May 31, 2016A Dock2 Duplication on Chr11
Accounts for the Observed N10-
Siae Phenotype
A focused examination of the whole-
genome sequence in the chr11:
30552213–35421130 region revealed an
2-fold increase in coverage in a
23.5 Kbp region encompassing exons
28 and 29 of the Dock2 gene (Figure 4A).
This was reminiscent of a previously
published report identifying a duplication
involving exons 28 and 29 of Dock2 in
Irf5/mice (Purtha et al., 2012). The pres-
ence of an identical duplication in Dock2
was confirmed in N10-Siae mice using a
previously reportedPCRdesigned to iden-
tify this duplication (Figure 4B) (Yasudaet al., 2013). Sequencing of the PCR product revealed that the
breakpoint in the Dock2 duplication (chr11:34329863–34306424;
GRCm38/mm10 assembly) was identical in Irf5/ and N10-Siae
mice (Figure S4). Because Cmah/ mice also lack MZ B cells
(Cariappaet al., 2009),we looked for the presenceof theDock2Hsd
allele in three Cmah/ mice. The Dock2Hsd allele was present in
all three Cmah/ mice analyzed (Figure 4B). This duplication
has been demonstrated to be a loss-of-function allele, because it
results in a frameshift mutation and nonsense-mediated decay of
Dock2mRNA (Purtha et al., 2012).
The Mutant Dock2 Allele Was Introduced by
Backcrossing into C57BL/6NHsd Mice
Given that the same duplication was seen in three independently
gene-targeted mice, it confirmed our suspicion that the mutant
Dock2 allele was inadvertently introduced during backcrossing.
As previously noted, the SNPs flanking the duplication were
of C57BL6/N origin (rs29473246 at chr11:33548367 and
rs29414108 at chr11:43358462), suggesting that this duplication
arose in a C57BL/6N substrain. A survey of several commercially
available C57BL6/N substrains showed the presence of a dupli-
cation in exons 28 and 29 of Dock2 with an identical breakpoint
in 44 of 44 C57BL/6NHsd mice analyzed (Figures 5A and S5).
We henceforth refer to this allele as Dock2Hsd. The Dock2Hsd
allele was not detected in any other C57BL/6N strains analyzed,
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Figure 4. A Genomic Segment Encoding Exons 28 and 29 of Dock2 Is Duplicated in N10-Siae and Cmah/ Mice
(A) An abrupt increase in coverage depth within the putative pathogenic locus on chr11mapped by SNPs encompasses exons 28 and 29 ofDock2 in the N10-Siae
genome.
(B) PCR detection of Dock2 duplication in N10-Siae, Cmah/, N23-Siae, and C57BL/6J mice.
See also Figures S3–S5.
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Figure 5. The Dock2 Duplication Is Present in the C57BL/6NHsd Strain, which Exhibits Multiple Characteristics of Dock2 Deficiency
(A) PCR detection of Dock2 duplication in C57BL/6NHsd mice and other C57BL6/N sublines (C57BL/6NTac and C57BL6/NJ).
(B) Sequences of the Dock2 duplication breakpoint (arrow) from C57BL/6NHsd, N10-Siae, and IRF5/ mice. A low-complexity sequence at the site of the
breakpoint is shown in lowercase.
(C) Proportion of CD8+MP cells, MZB cells, invariant NK T cells, and plasmacytoid dendritic cells in C57BL/6NHsd, C57BL/6NTac, and C57BL/6Jmice. The data
shown are representative of five mice each.
See also Figure S5.
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viz. C57BL/6NTac, C57BL/6NCrl, and C57BL/6NJ (Figure S5).
This Dock2 duplication was also not observed in the C57BL/
6NJ genome published by the Mouse Genomes Project (Well-
come Trust Sanger Institute) (Yalcin et al., 2012). Thus, the
Dock2Hsd allele appears to be a copy-number variant that has
been fixed in the C57BL/6NHsd strain and may have been intro-
duced into numerous other gene-targeted mouse lines during
backcrossing. Consistent with this, both SiaeDex2/Dex2 and
Cmah/ mice were generated from ESCs of 129 origin and
backcrossed into the C57BL/6 background at UCSD using
mice obtained from Harlan in the early 2000s.
The Irf5/ mice were generated from an E14K ESC
(129OlaHsd background) and backcrossed into the C57BL/6
background before being distributed to various investigators
from a laboratory in Japan (Takaoka et al., 2005). However, the
Dock2 duplication was found only in two of three colonies
derived from the original Irf5/ colony, which led the investiga-
tors to believe that the Dock2 duplication arose spontaneously
within a subline of Irf5/ mice (Purtha et al., 2012). Like the
N10-Siae mice, the C57BL/6NHsd mice exhibit an expansion
of CD8+ MP T cells (Figures 5C and S5). The C57BL/6NHsd
mice also exhibit other phenotypes that have been previously
observed in the Dock2/ mice (Fukui et al., 2001). Both
Dock2/ and C57BL/6NHsd mice exhibit splenic cytopenia,
as well as a profound loss of MZ B cells, invariant natural killer
(NK) T cells, and plasmacytoid dendritic cells (Figure 5C) (Fukui
et al., 2001; Gotoh et al., 2008; Kunisaki et al., 2006). The similar-
ities between Dock2/ and C57BL/6NHsd mice support the
notion that the Dock2Hsd allele inactivates the function of
Dock2 by creating a premature stop codon that contributes to
non-sense-mediated decay of the resultant mRNA.
DISCUSSION
Striking phenotypes have been discovered in a number of gene-
targeted mice that were previously assumed to be the result of
the homozygous loss of a specific gene. To explain the loss of
phenotypes in SiaeDex2/Dex2 upon further backcrossing into the
C57BL/6J background, we generated an additional mutant allele
of Siae. This mutant mouse also lacked the phenotypes that we
had previously reported.
To explain this loss of immune phenotypes, we undertook a
series of studies involving conventional genetics, whole-genome
genotyping, and whole-genome sequencing. This allowed us to
identify a causal mutation on chr11 that was responsible for the
previously observed immune phenotypes, such as the loss ofMZ
B cells and the increase in CD8+ MP T cells, in SiaeDex2/Dex2
mice.We then found this samemutation, a homozygous duplica-
tion of two exons ofDock2 that creates a non-functional product,
in a subset ofCmahmutantmice. An identical mutation had been
previously found in Irf5/ mice, originally generated in Japan,
and had been assumed to have arisen as a spontaneous muta-
tion (Purtha et al., 2012; Takaoka et al., 2005). Themost parsimo-
nious explanation for a specific mutation being present in three
different gene-targeted mice all derived from different ESCs,
with two generated originally in California and a third generated
in Japan, is that they had all been acquired by backcrossing into
an unidentified mutant C57BL/6 strain. Although the loss of MZB cells in Cmah mutant mice may be ascribed to the acquired
Dock2 mutation, other phenotypes have been reported in these
mice that may relate to the absence of the N-glycolyl form of
sialic acid observed in the absence of the Cmah protein (Naito
et al., 2007). Thus, it remains possible that some functional phe-
notypes in such mice are related to altered interactions between
sialic acids and Siglecs.
Because our SNP arrays showed the presence of specific
C57BL/6N SNPs, we had a high degree of suspicion that thismu-
tation had been acquired from a commercial C57BL/6N strain.
We surveyed commercial C57BL/6N sublines and discovered
that this Dock2 gene duplication that was present only in
C57BL/6N mice obtained from Harlan (C57BL/6NHsd). The set
of 123 SNPs outside the Siae locus that differed between N10-
Siae and C57BL/6J also comprised 97% of the SNP alleles
(n = 128) from a pool of 538,667 SNPs analyzed in the whole-
genome arrays that differ between C57BL/6J and C57BL/6N
sublines but are identical to the consensus 129 alleles. Given
that C57BL/6J and C57BL/6N strains were derived from a com-
mon stock of C57BL/6 mice, the differences between C57BL/6J
and C57BL/6N substrains have been attributed so far to genetic
drift. In contrast, our analysis indicates that C57BL/6N mice may
have derived some genetic contribution from the 129 strain at a
remote time during their history, before the divergence of various
C57BL/6N sublines.
SiaeDex2/Dex2 and Cmah-deficient mice were originally back-
crossed into the C57BL/6 background using mice obtained
from Harlan between 2005 and 2008. Currently available Cmah
mutant mice that have been backcrossed into other C57BL/6
backgrounds lack the Dock2 mutation. Initial reports of Irf5/
mice backcrossed into the C57BL/6 background that bear phe-
notypes (e.g., lack of type I interferon) attributable to Dock2 defi-
ciency were published in 2007 (Gotoh et al., 2010, 2008; Yasuda
et al., 2007). Thus, we believe that the Dock2 copy-number
variant has been present in the C57BL/6NHsd colony at Harlan
for at least a decade. The C57BL/6NHsd mice were derived by
Harlan from the breeding nucleus of the C57BL/6N colony main-
tained at the NIH in 1988. Harlan was acquired by Envigo Bio-
sciences in 2015. The C57BL/6N subline originated from
the C57BL/6J colony at Jackson Laboratory in 1951 (Mekada
et al., 2009). Given that other sublines derived from C57BL/6N
and C57BL/6J strains lack the Dock2Hsd variant, it is formally
possible that a spontaneous mutation present in the C57BL/6N
founders was expanded at Harlan. However, it is more likely
that the Dock2 duplication arose later in the C57BL/6NHsd col-
ony after it diverged from the NIH breeding stock and was fixed
by the breeding strategies based on continued brother-sister
mating that are designed to minimize genetic drift in mouse sub-
lines. Analysis of archived tissues from C57BL/6NHsd mice will
help estimate when the Dock2Hsd variant arose and help assess
how many studies have been affected. Despite the relatively
large size of the Dock2 gene, coding variants of Dock2 have
not been reported in other inbred mouse strains (Sherry et al.,
2001).
The Dock2Hsd variant is particularly significant because it
causes wide-ranging hematopoietic phenotypes in a strain
of mice that is widely used for immunological studies. Since
2003, Jackson Laboratory has implemented a Genetic StabilityCell Reports 15, 1901–1909, May 31, 2016 1907
Program in selected mouse strains to limit cumulative genetic
drift, including that caused by copy-number variation, by regu-
larly rebuilding foundation stocks from cryopreserved, pedi-
greed embryos every few generations (Taft et al., 2006).
Commercial breeders of inbredmouse strains, as well as individ-
ual research groups maintaining knockout lines over long pe-
riods, should consider the implications of the choice of their
breeding strategies on genetic drift within the colony.
The recent availability of ESCs from a C57BL/6 background
obviates the need for backcrossing, but ESCs derived from
the C57BL/6NHsd background should be tested for the pres-
ence of the Dock2Hsd allele (Skarnes et al., 2011). Given that
Dock2 is expressed primarily in the hematopoietic lineage, im-
mune phenotypes that have been studied in the context of B6
mice from Harlan should be reviewed carefully. The Dock2Hsd
allele has likely affected the interpretation of a large number of
studies in which C57BL/6NHsd mice obtained from Harlan
were used as controls. We have identified a large number of
studies in the literature that suggest to us that a plethora of
assumed phenotypes should be revisited. A PCR screening pro-
tocol for the Dock2Hsd allele is included in the Supplemental
Experimental Procedures.
Loss-of-function variants of other genes, such as Nnt,Mnrn1,
Rd8, and Cyfip2, have been described in one or more sublines
of C57BL/6 and have been linked to glucose intolerance,
impaired platelet function, retinal degeneration, and altered
cocaine response, respectively (Freeman et al., 2006; Kumar
et al., 2013; Mattapallil et al., 2012; Reheman et al., 2010).
Loss-of-function variants of Scna are seen in some sublines of
C57BL/6N, as well as in ESCs of C57BL/6N origin, but result in
no obvious phenotype (Specht and Schoepfer, 2001). A copy-
number variant that alters the expression of insulin-degrading
enzyme (Ide) and fibroblast growth factor binding protein 3
(Fgfbp3) genes has been reported to have achieved a high allele
frequency in C57BL/6J mice (Watkins-Chow and Pavan, 2008).
While it is difficult to estimate the precise degree of genetic
drift that results in deleterious or loss-of-functionmutations, sub-
line-specific variants can occur and should be considered as
possible causes of phenotypic discrepancies in mouse sublines.
Furthermore, the specific substrain of mice used for experiments
or for backcrossing should be clearly documented.EXPERIMENTAL PROCEDURES
Mice
An ESC clone (EPD0679_2_E06) bearing a targeted disruption of the Siae lo-
cus (Siaetm1a(EUCOMM)Wtsi; MGI: 4842607) was obtained from the European
Conditional Mouse Mutagenesis Program (EUCOMM) (Collins et al., 2007).
The Siaetm1a(EUCOMM)Wtsi allele (Siaetm1a) contains a beta-galactosidase re-
porter and a polyadenylation signal in intron 3 of Siae. Gene targeting had
been initially confirmed using long-range PCR by EUCOMM and additionally
validated by us with a Southern blot using the non-isotopic BrightStar Bio-
detect kit (Ambion) (Figure S1). The ESCs were then injected into C57BL/6
blastocysts at the Transgenic Core Facility at Brigham andWomen’s Hospital.
The resulting chimeric mice were crossed into C57BL/6NTac. An Siaetm1a
founder was backcrossed for one generation into C57BL/6NTac and inter-
crossed to obtain Siaetm1a/tm1a homozygous mice. C57BL/6NHsd mice were
purchased from Harlan Sprague Dawley (acquired by Envigo Biosciences
in 2015). All mouse experimental protocols were reviewed and approved by
the Institutional Animal Care and Use Committee.1908 Cell Reports 15, 1901–1909, May 31, 2016Genetic Mapping
Whole-genome SNP arrays were performed at the Microarray Core Facility at
the Dana Farber Cancer Institute using the Affymetrix Mouse Diversity Array
platform. Analysis was performed using the Affymetrix Genotyping Console
v.4.2.0.26. Publicly available SNP array data from various 129 substrains
and C57BL/6 sublines were used for comparison (Didion et al., 2012). We
focused on 538,667 SNPs that did not show any intra-strain variation among
all C57BL/6N substrains, all 129 strains, and both N10-Siae mice analyzed.
These were intended to represent the ancestral alleles of the 129 and
C57BL6/N strains. Candidate SNPs were evaluated using PCR and Sanger
sequencing. Sequencing chromatograms were analyzed using Mutation
Surveyor v.3.24 (Softgenetics).
Whole-Genome Sequencing
A whole-genome library was constructed using the Kapa HyperPlus kit
following manufacturer’s recommendations. Briefly, 1 mg of genomic DNA
was enzymatically fragmented, end repaired, deoxyadenosine (dA)-tailed,
and ligated to Illumina Truseq adapters. No library amplification was per-
formed to avoid introducing any coverage bias. The library was sequenced
on the Illumina NextSeq 500 for 85 cycles using the NextSeq 500/550 High
Output v.2 kit. A total of 567,104,840 single-end reads were aligned to the
Mus musculus genome (GRCm38/mm10, December 2011 build) using Bow-
tie2 (Langmead and Salzberg, 2012). For 93.96% of reads mapping to the
reference genome, 65.42% of reads mapped to unique sites on the genome
and 28.54% of reads mapped to multiple regions. The GATK pipeline was
used to identify variants (McKenna et al., 2010). Variants with quality scores <
30 or allele frequency < 100% were excluded, yielding 35,340 variants.
Variant and read densities were calculated using BEDtools on Galaxy and
visualized using the R statistical programming language (Quinlan and Hall,
2010).
Flow Cytometry
Mouse splenocytes or peripheral blood was hemolyzed with ammonium-chlo-
ride-potassium (ACK) buffer and stained with fluorescently conjugated anti-
bodies analyzed on a BD LSR II flow cytometer. The following antibody clones
were used in this study: anti-CD122 (TMB1), anti-CD44 (IM7), anti-CD3 (17A2),
anti-CD8 (53-6.7), anti-CD19 (6D5), anti-B220 (RA3-6B2), anti-CD21 (7E9),
anti-IgM (RMM-1), anti-CD1d (1B1), and anti-IgD (11-26c.2a) from BioLegend.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism 6. The significance
of differences between groups was evaluated using Student’s t test.
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The accession number for the whole genome sequence of the N10-Siae
mouse reported in this paper is NCBI Sequence Read Archive: SRA409984.
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